Semaphorin 7a + Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1–induced Pulmonary Fibrosis
Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation. To define the relationship between Sema 7a and lymphocytes in IPF. We characterized the significance of Sema 7a+ lymphocytes in humans with IPF and in a mo...
Saved in:
Published in | American journal of respiratory and critical care medicine Vol. 187; no. 2; pp. 180 - 188 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
American Thoracic Society
15.01.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation.
To define the relationship between Sema 7a and lymphocytes in IPF.
We characterized the significance of Sema 7a+ lymphocytes in humans with IPF and in a mouse model of lung fibrosis caused by lung-targeted, transgenic overexpression of TGF-β1. We determined the site of Sema 7a expression in human and murine lungs and circulation and used adoptive transfer approaches to define the relevance of lymphocytes coexpressing Sema7a and the markers CD19, CD4, or CD4+CD25+FoxP3+ in TGF-β1-induced murine lung fibrosis.
Subjects with IPF show expression of Sema 7a on lung CD4+ cells and circulating CD4+ or CD19+ cells. Sema 7a expression is increased on CD4+ cells and CD4+CD25+FoxP3+ regulatory T cells, but not CD19+ cells, in subjects with progressive IPF. Sema 7a is expressed on lymphocytes expressing CD4 but not CD19 in the lungs and spleen of TGF-β1-transgenic mice. Sema 7a expressing bone marrow-derived cells induce lung fibrosis and alter the production of T-cell mediators, including IFN-γ, IL-4, IL-17A, and IL-10. These effects require CD4 but not CD19. In comparison to Sema 7a-CD4+CD25+FoxP3+ cells, Sema7a+CD4+CD25+FoxP3+ cells exhibit reduced expression of regulatory genes such as IL-10, and adoptive transfer of these cells induces fibrosis and remodeling in the TGF-β1-exposed murine lung.
Sema 7a+CD4+CD25+FoxP3+ regulatory T cells are associated with disease progression in subjects with IPF and induce fibrosis in the TGF-β1-exposed murine lung. |
---|---|
AbstractList | Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation.
To define the relationship between Sema 7a and lymphocytes in IPF.
We characterized the significance of Sema 7a+ lymphocytes in humans with IPF and in a mouse model of lung fibrosis caused by lung-targeted, transgenic overexpression of TGF-β1. We determined the site of Sema 7a expression in human and murine lungs and circulation and used adoptive transfer approaches to define the relevance of lymphocytes coexpressing Sema7a and the markers CD19, CD4, or CD4+CD25+FoxP3+ in TGF-β1-induced murine lung fibrosis.
Subjects with IPF show expression of Sema 7a on lung CD4+ cells and circulating CD4+ or CD19+ cells. Sema 7a expression is increased on CD4+ cells and CD4+CD25+FoxP3+ regulatory T cells, but not CD19+ cells, in subjects with progressive IPF. Sema 7a is expressed on lymphocytes expressing CD4 but not CD19 in the lungs and spleen of TGF-β1-transgenic mice. Sema 7a expressing bone marrow-derived cells induce lung fibrosis and alter the production of T-cell mediators, including IFN-γ, IL-4, IL-17A, and IL-10. These effects require CD4 but not CD19. In comparison to Sema 7a-CD4+CD25+FoxP3+ cells, Sema7a+CD4+CD25+FoxP3+ cells exhibit reduced expression of regulatory genes such as IL-10, and adoptive transfer of these cells induces fibrosis and remodeling in the TGF-β1-exposed murine lung.
Sema 7a+CD4+CD25+FoxP3+ regulatory T cells are associated with disease progression in subjects with IPF and induce fibrosis in the TGF-β1-exposed murine lung. Rationale : Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation. Objectives : To define the relationship between Sema 7a and lymphocytes in IPF. Methods : We characterized the significance of Sema 7a + lymphocytes in humans with IPF and in a mouse model of lung fibrosis caused by lung-targeted, transgenic overexpression of TGF-β1. We determined the site of Sema 7a expression in human and murine lungs and circulation and used adoptive transfer approaches to define the relevance of lymphocytes coexpressing Sema7a and the markers CD19, CD4, or CD4 + CD25 + FoxP3 + in TGF-β1–induced murine lung fibrosis. Measurements and Main Results : Subjects with IPF show expression of Sema 7a on lung CD4 + cells and circulating CD4 + or CD19 + cells. Sema 7a expression is increased on CD4 + cells and CD4 + CD25 + FoxP3 + regulatory T cells, but not CD19 + cells, in subjects with progressive IPF. Sema 7a is expressed on lymphocytes expressing CD4 but not CD19 in the lungs and spleen of TGF-β1–transgenic mice. Sema 7a expressing bone marrow–derived cells induce lung fibrosis and alter the production of T-cell mediators, including IFN-γ, IL-4, IL-17A, and IL-10. These effects require CD4 but not CD19. In comparison to Sema 7a-CD4 + CD25 + FoxP3 + cells, Sema7a + CD4 + CD25 + FoxP3 + cells exhibit reduced expression of regulatory genes such as IL-10, and adoptive transfer of these cells induces fibrosis and remodeling in the TGF-β1–exposed murine lung. Conclusions : Sema 7a + CD4 + CD25 + FoxP3 + regulatory T cells are associated with disease progression in subjects with IPF and induce fibrosis in the TGF-β1–exposed murine lung. Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation.RATIONALELymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation.To define the relationship between Sema 7a and lymphocytes in IPF.OBJECTIVESTo define the relationship between Sema 7a and lymphocytes in IPF.We characterized the significance of Sema 7a+ lymphocytes in humans with IPF and in a mouse model of lung fibrosis caused by lung-targeted, transgenic overexpression of TGF-β1. We determined the site of Sema 7a expression in human and murine lungs and circulation and used adoptive transfer approaches to define the relevance of lymphocytes coexpressing Sema7a and the markers CD19, CD4, or CD4+CD25+FoxP3+ in TGF-β1-induced murine lung fibrosis.METHODSWe characterized the significance of Sema 7a+ lymphocytes in humans with IPF and in a mouse model of lung fibrosis caused by lung-targeted, transgenic overexpression of TGF-β1. We determined the site of Sema 7a expression in human and murine lungs and circulation and used adoptive transfer approaches to define the relevance of lymphocytes coexpressing Sema7a and the markers CD19, CD4, or CD4+CD25+FoxP3+ in TGF-β1-induced murine lung fibrosis.Subjects with IPF show expression of Sema 7a on lung CD4+ cells and circulating CD4+ or CD19+ cells. Sema 7a expression is increased on CD4+ cells and CD4+CD25+FoxP3+ regulatory T cells, but not CD19+ cells, in subjects with progressive IPF. Sema 7a is expressed on lymphocytes expressing CD4 but not CD19 in the lungs and spleen of TGF-β1-transgenic mice. Sema 7a expressing bone marrow-derived cells induce lung fibrosis and alter the production of T-cell mediators, including IFN-γ, IL-4, IL-17A, and IL-10. These effects require CD4 but not CD19. In comparison to Sema 7a-CD4+CD25+FoxP3+ cells, Sema7a+CD4+CD25+FoxP3+ cells exhibit reduced expression of regulatory genes such as IL-10, and adoptive transfer of these cells induces fibrosis and remodeling in the TGF-β1-exposed murine lung.MEASUREMENTS AND MAIN RESULTSSubjects with IPF show expression of Sema 7a on lung CD4+ cells and circulating CD4+ or CD19+ cells. Sema 7a expression is increased on CD4+ cells and CD4+CD25+FoxP3+ regulatory T cells, but not CD19+ cells, in subjects with progressive IPF. Sema 7a is expressed on lymphocytes expressing CD4 but not CD19 in the lungs and spleen of TGF-β1-transgenic mice. Sema 7a expressing bone marrow-derived cells induce lung fibrosis and alter the production of T-cell mediators, including IFN-γ, IL-4, IL-17A, and IL-10. These effects require CD4 but not CD19. In comparison to Sema 7a-CD4+CD25+FoxP3+ cells, Sema7a+CD4+CD25+FoxP3+ cells exhibit reduced expression of regulatory genes such as IL-10, and adoptive transfer of these cells induces fibrosis and remodeling in the TGF-β1-exposed murine lung.Sema 7a+CD4+CD25+FoxP3+ regulatory T cells are associated with disease progression in subjects with IPF and induce fibrosis in the TGF-β1-exposed murine lung.CONCLUSIONSSema 7a+CD4+CD25+FoxP3+ regulatory T cells are associated with disease progression in subjects with IPF and induce fibrosis in the TGF-β1-exposed murine lung. |
Author | Shaw, Albert Reilkoff, Ronald A. Feghali-Bostwick, Carol Mathur, Aditi Herzog, Erica L. Peng, Hong Homer, Robert J. Elias, Jack A. Montgomery, Ruth Russell, Thomas Peng, Xueyan Gulati, Mridu Murray, Lynne A. |
Author_xml | – sequence: 1 givenname: Ronald A. surname: Reilkoff fullname: Reilkoff, Ronald A. organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut – sequence: 2 givenname: Hong surname: Peng fullname: Peng, Hong organization: Department of Respiratory Medicine, Second Xiangyia Hospital of Central-South University, Changsha, Hunan, PR China – sequence: 3 givenname: Lynne A. surname: Murray fullname: Murray, Lynne A. organization: MedImmune Ltd, Granta Park, Cambridgeshire, United Kingdom – sequence: 4 givenname: Xueyan surname: Peng fullname: Peng, Xueyan organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut – sequence: 5 givenname: Thomas surname: Russell fullname: Russell, Thomas organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut – sequence: 6 givenname: Ruth surname: Montgomery fullname: Montgomery, Ruth organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut – sequence: 7 givenname: Carol surname: Feghali-Bostwick fullname: Feghali-Bostwick, Carol organization: Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania; and – sequence: 8 givenname: Albert surname: Shaw fullname: Shaw, Albert organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut – sequence: 9 givenname: Robert J. surname: Homer fullname: Homer, Robert J. organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, Department of Pathology, West Haven Veterans Affairs Medical Center, West Haven, Connecticut – sequence: 10 givenname: Mridu surname: Gulati fullname: Gulati, Mridu organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut – sequence: 11 givenname: Aditi surname: Mathur fullname: Mathur, Aditi organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut – sequence: 12 givenname: Jack A. surname: Elias fullname: Elias, Jack A. organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut – sequence: 13 givenname: Erica L. surname: Herzog fullname: Herzog, Erica L. organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, Department of Pathology, West Haven Veterans Affairs Medical Center, West Haven, Connecticut |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26898096$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23220917$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1u1DAUhSNURH_gBVggb5CQqhT_JHGyQRqNmDJSpVYwC3bWzY0zY5TYwU5aseMd-iZ9EB6CJ8HTGcqfxMqW_J1z7OtznBxYZ3WSPGf0jLEie-0R-zNOGadFyhitLuePkiOWizzNKkkP4p5KkWZZ9fEwOQ7hE41oyeiT5JALzmnF5FFy90H3MGycN5ZIIKfkvV5PHYzOfyErMtddF8jMazILwaGBUTfkxowbcuXd2usQzLUmy8a4AcaNQXI1db2zEMULU3sXTCBgm3uHZT90Bu8dYtbKgw2t872xa3Lu3U30XADG3PTbHfv-9dbYZsLI_uv4NHncQhf0s_16kqwWb1fzd-nF5flyPrtIUWQS0zJrUZdcV1CCyBBBY8MKKCQ0dc0ow7zlwOqGF1ICLWkDZY2iroq6haqS4iR5s7MdprrXDWo7eujU4E0fb6McGPXniTUbtXbXSuSSFrmIBq_2Bt59nnQYVW8CxomC1W4KinEp8jKiRURf_J71EPLznyLwcg9AQOjaOD004RdXlFVJq60R33EYRxW8bh8QRtW2NGpbGrUrjdqVJorKv0RoRhiN277LdP-T_gB0rs7B |
CitedBy_id | crossref_primary_10_1186_s13075_020_2112_7 crossref_primary_10_1155_2019_1907807 crossref_primary_10_3390_ijms25136847 crossref_primary_10_3390_jcm10071427 crossref_primary_10_1038_s41388_020_1192_9 crossref_primary_10_1371_journal_pone_0275987 crossref_primary_10_1007_s12026_013_8460_5 crossref_primary_10_1165_rcmb_2017_0171TR crossref_primary_10_1177_1753425919861774 crossref_primary_10_1164_rccm_202306_0979OC crossref_primary_10_1152_ajplung_00014_2014 crossref_primary_10_1371_journal_pone_0170207 crossref_primary_10_3389_fimmu_2016_00516 crossref_primary_10_1016_j_rmed_2018_12_015 crossref_primary_10_1016_j_redox_2015_09_009 crossref_primary_10_1016_j_matbio_2018_01_023 crossref_primary_10_1038_icb_2017_22 crossref_primary_10_4081_dr_2024_10106 crossref_primary_10_18093_0869_0189_2017_27_1_56_64 crossref_primary_10_1016_j_cellsig_2020_109647 crossref_primary_10_1016_j_matbio_2023_06_006 crossref_primary_10_1172_JCI125014 crossref_primary_10_1126_scitranslmed_aar8356 crossref_primary_10_1172_JCI136542 crossref_primary_10_1016_j_ajpath_2016_03_020 crossref_primary_10_1016_j_yjmcc_2017_11_001 crossref_primary_10_1371_journal_pone_0159878 crossref_primary_10_1007_s12035_016_0154_2 crossref_primary_10_1016_S2213_2600_18_30508_3 crossref_primary_10_2147_IJGM_S474827 crossref_primary_10_3389_fmed_2014_00056 crossref_primary_10_1007_s40139_013_0017_8 crossref_primary_10_1155_2019_9019648 crossref_primary_10_1096_fj_201600373R crossref_primary_10_3389_fimmu_2024_1436491 crossref_primary_10_1016_j_yrmex_2019_100002 crossref_primary_10_1016_j_jbior_2023_100975 crossref_primary_10_1016_j_semarthrit_2020_01_006 crossref_primary_10_3389_fimmu_2021_690375 crossref_primary_10_1007_s40259_020_00437_8 crossref_primary_10_1080_17476348_2019_1553620 crossref_primary_10_1097_MCP_0000000000000187 crossref_primary_10_1186_1755_1536_6_20 crossref_primary_10_1007_s10157_018_1542_x crossref_primary_10_1126_scitranslmed_3007096 crossref_primary_10_1016_S2213_2600_17_30349_1 crossref_primary_10_3389_fimmu_2021_663203 crossref_primary_10_3389_fphar_2022_918771 crossref_primary_10_1016_j_prp_2023_154901 crossref_primary_10_3389_fgene_2025_1544007 crossref_primary_10_1111_crj_12281 crossref_primary_10_1002_jcp_30340 crossref_primary_10_1038_pr_2013_222 crossref_primary_10_1183_16000617_0117_2017 crossref_primary_10_1111_apm_13445 crossref_primary_10_1155_2023_4835710 crossref_primary_10_1172_jci_insight_92192 crossref_primary_10_1136_bmjresp_2023_001763 crossref_primary_10_70322_fibrosis_2025_10004 crossref_primary_10_1016_j_clim_2013_11_009 crossref_primary_10_1111_jcmm_14186 crossref_primary_10_3389_fphar_2014_00080 crossref_primary_10_1186_s12931_017_0653_3 crossref_primary_10_1615_CritRevImmunol_2023047301 crossref_primary_10_3390_cimb46090609 crossref_primary_10_1183_13993003_01826_2015 crossref_primary_10_12688_f1000research_8209_1 crossref_primary_10_1016_j_pharmthera_2019_05_014 crossref_primary_10_1016_j_intimp_2020_106443 crossref_primary_10_1016_j_ajpath_2016_06_002 crossref_primary_10_1111_resp_12144 crossref_primary_10_1164_rccm_201405_0856UP crossref_primary_10_1164_rccm_201902_0318ED crossref_primary_10_1016_j_ebiom_2023_104766 crossref_primary_10_3389_fmed_2018_00043 crossref_primary_10_1007_s10238_022_00945_7 crossref_primary_10_1186_s12967_016_1008_4 crossref_primary_10_1186_s12916_015_0403_7 crossref_primary_10_1007_s00408_017_9993_5 crossref_primary_10_1146_annurev_physiol_021113_170411 crossref_primary_10_1016_j_chest_2024_10_042 crossref_primary_10_3389_fmed_2022_955125 crossref_primary_10_1016_j_crimmu_2023_100060 crossref_primary_10_1002_advs_202415007 crossref_primary_10_1097_MCP_0b013e328363f4b7 crossref_primary_10_1002_ctd2_70003 crossref_primary_10_1111_imr_12801 crossref_primary_10_4049_jimmunol_2100767 crossref_primary_10_1586_17476348_2015_1062367 crossref_primary_10_1164_rccm_202003_0669OC crossref_primary_10_1002_path_5838 crossref_primary_10_1158_0008_5472_CAN_18_1642 crossref_primary_10_1038_s41420_023_01344_x crossref_primary_10_3389_fimmu_2022_865593 crossref_primary_10_1152_ajplung_00100_2013 crossref_primary_10_3389_fmicb_2022_943791 crossref_primary_10_1080_14728222_2022_2114897 crossref_primary_10_3389_fimmu_2024_1450688 crossref_primary_10_4049_jimmunol_1600610 |
Cites_doi | 10.4049/jimmunol.1102084 10.1152/ajplung.00439.2007 10.1016/j.immuni.2008.02.012 10.1084/jem.20092121 10.1164/rccm.200703-463PP 10.1084/jem.20040104 10.1038/nature01790 10.5858/2010-0296-RA.1 10.1186/1755-1536-3-18 10.1038/labinvest.2010.73 10.1038/nature05652 10.1002/jlb.65.2.187 10.1002/art.30386 10.1371/journal.pone.0009683 10.1016/j.ajpath.2012.01.010 10.1164/rccm.2009-040GL 10.1164/rccm.201103-0516OC 10.1016/j.immuni.2006.03.013 10.1002/dneu.20592 10.4049/jimmunol.1201140 10.2353/ajpath.2008.071049 10.1371/journal.pone.0015404 10.1371/journal.pone.0005981 10.1189/jlb.0707504 10.1038/nprot.2007.258 10.1016/j.biocel.2010.10.013 10.1164/ajrccm.165.2.ats01 10.1164/rccm.200812-1936OC 10.1371/journal.pone.0008959 10.1172/JCI36498 10.3748/wjg.v17.i3.343 |
ContentType | Journal Article |
Copyright | 2014 INIST-CNRS Copyright © 2013 by the American Thoracic Society 2013 |
Copyright_xml | – notice: 2014 INIST-CNRS – notice: Copyright © 2013 by the American Thoracic Society 2013 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1164/rccm.201206-1109OC |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1535-4970 |
EndPage | 188 |
ExternalDocumentID | PMC3570653 23220917 26898096 10_1164_rccm_201206_1109OC |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: K24 AG042489 – fundername: NHLBI NIH HHS grantid: U01 HL112702-01 – fundername: NIAID NIH HHS grantid: HHSN272201100019C – fundername: NHLBI NIH HHS grantid: R01 HL109033 – fundername: NHLBI NIH HHS grantid: R01 HL109233 – fundername: NHLBI NIH HHS grantid: U01 HL112702 – fundername: NIAID NIH HHS grantid: HHSN272201100019I |
GroupedDBID | --- -~X .55 0R~ 23M 2WC 34G 39C 53G 5GY 5RE 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8FW 8R4 8R5 AAWTL AAYXX ABJNI ABOCM ABPMR ABUWG ACGFO ACGFS ADBBV AENEX AFCHL AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 BAWUL BENPR BKEYQ BNQBC BPHCQ BVXVI C45 CCPQU CITATION CS3 DIK E3Z EBS EJD EMOBN EX3 F5P FRP FYUFA GX1 H13 HMCUK HZ~ IH2 J5H KQ8 L7B M1P M5~ NAPCQ O9- OBH OFXIZ OGEVE OK1 OVD OVIDX P2P PCD PHGZM PHGZT PQQKQ PROAC PSQYO Q2X RWL SJN TAE TEORI THO TR2 UKHRP W8F WH7 WOQ WOW X7M ZXP ~02 .GJ 1CY 1KJ 3O- AAEJM AAQQT ACBNA AFFNX AFUWQ AI. AJJEV IQODW N4W OHT PJZUB PPXIY VH1 YJK ZE2 ZGI CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c347c-84fce82e9a8a34ccaecd16a67adbb101c5f2a1bd2677a080da8bc3b96bfa9973 |
ISSN | 1073-449X 1535-4970 |
IngestDate | Thu Aug 21 18:28:17 EDT 2025 Tue Aug 05 11:24:15 EDT 2025 Mon Jul 21 05:56:37 EDT 2025 Mon Jul 21 09:13:59 EDT 2025 Tue Jul 01 00:53:41 EDT 2025 Thu Apr 24 23:06:06 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Lung disease Intensive care Respiratory disease Idiopathic lung regulatory T cells Pulmonary fibrosis T-Lymphocyte TGF-β1 fibrosis Transforming growth factor β1 Resuscitation Semaphorin |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c347c-84fce82e9a8a34ccaecd16a67adbb101c5f2a1bd2677a080da8bc3b96bfa9973 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3570653 |
PMID | 23220917 |
PQID | 1273580656 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3570653 proquest_miscellaneous_1273580656 pubmed_primary_23220917 pascalfrancis_primary_26898096 crossref_primary_10_1164_rccm_201206_1109OC crossref_citationtrail_10_1164_rccm_201206_1109OC |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-01-15 |
PublicationDateYYYYMMDD | 2013-01-15 |
PublicationDate_xml | – month: 01 year: 2013 text: 2013-01-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | American journal of respiratory and critical care medicine |
PublicationTitleAlternate | Am J Respir Crit Care Med |
PublicationYear | 2013 |
Publisher | American Thoracic Society |
Publisher_xml | – name: American Thoracic Society |
References | bib14 bib15 bib12 bib13 bib10 bib32 bib11 bib30 bib31 bib29 bib27 bib28 Gan Y (bib2) 2011; 7 bib25 bib26 bib23 bib24 bib21 bib22 bib20 bib9 bib7 bib8 bib5 bib18 bib6 bib19 bib3 bib16 bib4 bib17 bib1 Wolf AM (bib33) 2003; 9 21339942 - Ther Clin Risk Manag. 2011 Feb 08;7:39-47 21044893 - Int J Biochem Cell Biol. 2011 Jan;43(1):154-62 15289506 - J Exp Med. 2004 Aug 2;200(3):377-89 17377534 - Nature. 2007 Apr 5;446(7136):680-4 11790668 - Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304 21072213 - PLoS One. 2010;5(11):e15404 17585107 - Am J Respir Crit Care Med. 2007 Oct 1;176(7):636-43 20300636 - PLoS One. 2010;5(3):e9683 18342004 - Immunity. 2008 Mar;28(3):302-3 21631273 - Arch Pathol Lab Med. 2011 Jun;135(6):780-8 21484765 - Arthritis Rheum. 2011 Aug;63(8):2484-94 22429962 - Am J Pathol. 2012 May;180(5):1963-78 19543397 - PLoS One. 2009;4(6):e5981 18044734 - Dev Neurobiol. 2008 Feb 15;68(3):317-31 20404807 - Lab Invest. 2010 Jun;90(6):812-23 20815874 - Fibrogenesis Tissue Repair. 2010 Sep 03;3:18 19342412 - Am J Respir Crit Care Med. 2009 Jun 15;179(12):1121-30 21471066 - Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824 22896629 - J Immunol. 2012 Sep 15;189(6):3150-8 16713976 - Immunity. 2006 May;24(5):591-600 10088601 - J Leukoc Biol. 1999 Feb;65(2):187-95 18375740 - Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1174-86 18467694 - Am J Pathol. 2008 Jun;172(6):1650-63 12879062 - Nature. 2003 Jul 24;424(6947):398-405 17962367 - J Leukoc Biol. 2008 Feb;83(2):237-44 22198947 - J Immunol. 2012 Feb 1;188(3):1108-16 19770521 - J Clin Invest. 2009 Oct;119(10):2898-913 21868503 - Am J Respir Crit Care Med. 2011 Dec 1;184(11):1270-81 12576425 - Clin Cancer Res. 2003 Feb;9(2):606-12 17641646 - Nat Protoc. 2007;2(7):1789-94 20126467 - PLoS One. 2010;5(1):e8959 21253393 - World J Gastroenterol. 2011 Jan 21;17(3):343-8 20176803 - J Exp Med. 2010 Mar 15;207(3):535-52 |
References_xml | – ident: bib8 doi: 10.4049/jimmunol.1102084 – ident: bib22 doi: 10.1152/ajplung.00439.2007 – ident: bib28 doi: 10.1016/j.immuni.2008.02.012 – volume: 9 start-page: 606 year: 2003 ident: bib33 publication-title: Clin Cancer Res – ident: bib13 doi: 10.1084/jem.20092121 – ident: bib26 doi: 10.1164/rccm.200703-463PP – ident: bib31 doi: 10.1084/jem.20040104 – volume: 7 start-page: 39 year: 2011 ident: bib2 publication-title: Ther Clin Risk Manag – ident: bib5 doi: 10.1038/nature01790 – ident: bib3 doi: 10.5858/2010-0296-RA.1 – ident: bib16 doi: 10.1186/1755-1536-3-18 – ident: bib23 doi: 10.1038/labinvest.2010.73 – ident: bib6 doi: 10.1038/nature05652 – ident: bib11 doi: 10.1002/jlb.65.2.187 – ident: bib9 doi: 10.1002/art.30386 – ident: bib25 doi: 10.1371/journal.pone.0009683 – ident: bib14 doi: 10.1016/j.ajpath.2012.01.010 – ident: bib1 doi: 10.1164/rccm.2009-040GL – ident: bib15 doi: 10.1164/rccm.201103-0516OC – ident: bib7 doi: 10.1016/j.immuni.2006.03.013 – ident: bib4 doi: 10.1002/dneu.20592 – ident: bib29 doi: 10.4049/jimmunol.1201140 – ident: bib12 doi: 10.2353/ajpath.2008.071049 – ident: bib17 doi: 10.1371/journal.pone.0015404 – ident: bib18 doi: 10.1371/journal.pone.0005981 – ident: bib10 doi: 10.1189/jlb.0707504 – ident: bib21 doi: 10.1038/nprot.2007.258 – ident: bib24 doi: 10.1016/j.biocel.2010.10.013 – ident: bib19 doi: 10.1164/ajrccm.165.2.ats01 – ident: bib27 doi: 10.1164/rccm.200812-1936OC – ident: bib30 doi: 10.1371/journal.pone.0008959 – ident: bib20 doi: 10.1172/JCI36498 – ident: bib32 doi: 10.3748/wjg.v17.i3.343 – reference: 18375740 - Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1174-86 – reference: 19342412 - Am J Respir Crit Care Med. 2009 Jun 15;179(12):1121-30 – reference: 21471066 - Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824 – reference: 22429962 - Am J Pathol. 2012 May;180(5):1963-78 – reference: 22896629 - J Immunol. 2012 Sep 15;189(6):3150-8 – reference: 21631273 - Arch Pathol Lab Med. 2011 Jun;135(6):780-8 – reference: 10088601 - J Leukoc Biol. 1999 Feb;65(2):187-95 – reference: 18044734 - Dev Neurobiol. 2008 Feb 15;68(3):317-31 – reference: 20404807 - Lab Invest. 2010 Jun;90(6):812-23 – reference: 21253393 - World J Gastroenterol. 2011 Jan 21;17(3):343-8 – reference: 21044893 - Int J Biochem Cell Biol. 2011 Jan;43(1):154-62 – reference: 17641646 - Nat Protoc. 2007;2(7):1789-94 – reference: 21072213 - PLoS One. 2010;5(11):e15404 – reference: 15289506 - J Exp Med. 2004 Aug 2;200(3):377-89 – reference: 19770521 - J Clin Invest. 2009 Oct;119(10):2898-913 – reference: 11790668 - Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304 – reference: 21868503 - Am J Respir Crit Care Med. 2011 Dec 1;184(11):1270-81 – reference: 20176803 - J Exp Med. 2010 Mar 15;207(3):535-52 – reference: 17377534 - Nature. 2007 Apr 5;446(7136):680-4 – reference: 18342004 - Immunity. 2008 Mar;28(3):302-3 – reference: 20126467 - PLoS One. 2010;5(1):e8959 – reference: 19543397 - PLoS One. 2009;4(6):e5981 – reference: 18467694 - Am J Pathol. 2008 Jun;172(6):1650-63 – reference: 17585107 - Am J Respir Crit Care Med. 2007 Oct 1;176(7):636-43 – reference: 21484765 - Arthritis Rheum. 2011 Aug;63(8):2484-94 – reference: 16713976 - Immunity. 2006 May;24(5):591-600 – reference: 12576425 - Clin Cancer Res. 2003 Feb;9(2):606-12 – reference: 20815874 - Fibrogenesis Tissue Repair. 2010 Sep 03;3:18 – reference: 17962367 - J Leukoc Biol. 2008 Feb;83(2):237-44 – reference: 21339942 - Ther Clin Risk Manag. 2011 Feb 08;7:39-47 – reference: 22198947 - J Immunol. 2012 Feb 1;188(3):1108-16 – reference: 12879062 - Nature. 2003 Jul 24;424(6947):398-405 – reference: 20300636 - PLoS One. 2010;5(3):e9683 |
SSID | ssj0012810 |
Score | 2.4176285 |
Snippet | Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation.
To define the... Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte... Rationale : Lymphocytes are increasingly associated with idiopathic pulmonary fibrosis (IPF). Semaphorin 7a (Sema 7a) participates in lymphocyte activation.... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 180 |
SubjectTerms | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Antigens, CD - physiology Biological and medical sciences CD4-Positive T-Lymphocytes - immunology CD4-Positive T-Lymphocytes - physiology Disease Models, Animal Humans Idiopathic Pulmonary Fibrosis - etiology Idiopathic Pulmonary Fibrosis - immunology Idiopathic Pulmonary Fibrosis - physiopathology Intensive care medicine Interleukin-10 - physiology Medical sciences Mice Mice, Inbred C57BL Mice, Transgenic Pneumology Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases Semaphorins - physiology T-Lymphocytes, Regulatory - physiology Transforming Growth Factor beta1 - physiology |
Title | Semaphorin 7a + Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1–induced Pulmonary Fibrosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23220917 https://www.proquest.com/docview/1273580656 https://pubmed.ncbi.nlm.nih.gov/PMC3570653 |
Volume | 187 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZpCmMwxu7LLkGD9cl4i-SL7MclpITRdiVzIW9GkuU2LEtCEg-6PzXYD9nzfs6OLN_ShNHtxQRbkk2-T9I50qdzEHobUL27xKmtZCpsVwTSBuPIs11PMdmTYCLnWSJOz_zRhftx4k1ard8N1VK2Ee_k973nSv4HVbgHuOpTsv-AbNUo3IDfgC9cAWG43grjz-orX15pCZ3FwAjsWyuTWV7vm0eWXpNfW1rZxQsMSql5LsrS-tdvypom00Wellhay2wGn65ldCk40QsdqiQP5QotTAvhuUpyYWRp7ep1hktw5KFNk7jHPhoMj_qU2ODqZ1pasNtm0xyu9osaASxWjc3__NBdmYwhF6nd1AKM1XT2ZWFCS47zde56dfZcmYFstCimZ0OsFTer9NcwxewWnmTquugxxWKITkxBbHMctBq_PZ00z2z1qD33qkGfNdhNG0M4MZmldqcW3wU-rKTU8QsI1emLSC8sIm9uxfE--xQfX5ycxNFwEh2gQwoODG2jw_7w7Hxc7XDRwETKKD-uPNDlu-9337FlNN1b8jX866lJvLLPM7op8G1YTNEDdL9wdfAHw9uHqKXmj9Cd0wLAx-hHTV_MuIVr8uII5-TFgDiuyYs1eXGDvLgmL66IhkuiYWBP3kJNXgyvapIXG_Ligry_flbE3dPeExQdD6PByC7yh9jScRkMOm4qVUBVyAPuuDBUKZkQn_uMJ0LAVCS9lHIiEuozxsFzSnggpCNCX6Q8DJnzFLXni7l6jrBPiQjTQPDU0fE0He44PeGSJJRKiCBJO4iU-MSyiK2vU7zM4tzH9t1YYxobTGODaQdZVZ2liSzz19LdLdirKtQPwqAX-h30puRBDDOERonP1SJbxwQ8FE_rJ6DMM8OLujbM5-AxsA5iW4ypCujo89tP5tOrPAq942mFhPPiFu99ie7WnfUVam9WmXoNtvxGdNEBmzC4BgPSLbrIHyakBfM |
linkProvider | ProQuest |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Semaphorin+7a%2B+regulatory+T+cells+are+associated+with+progressive+idiopathic+pulmonary+fibrosis+and+are+implicated+in+transforming+growth+factor-%CE%B21-induced+pulmonary+fibrosis&rft.jtitle=American+journal+of+respiratory+and+critical+care+medicine&rft.au=Reilkoff%2C+Ronald+A&rft.au=Peng%2C+Hong&rft.au=Murray%2C+Lynne+A&rft.au=Peng%2C+Xueyan&rft.date=2013-01-15&rft.issn=1535-4970&rft.eissn=1535-4970&rft.volume=187&rft.issue=2&rft.spage=180&rft_id=info:doi/10.1164%2Frccm.201206-1109OC&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-449X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-449X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-449X&client=summon |